Relationship between disease severity and quality of life and assessment of health care utilization and cost for ulcerative colitis in Australia: A cross-sectional, observational study
Tao Fan(Merck & Co., Inc., Rahway, NJ, USA (United States)), Peter A. Bampton(Flinders University), Rupert W. Leong(The University of Sydney), Ian C. Lawrance(The University of Western Australia), Martin Weltman(Nepean Hospital), Jane M. Andrews(Health Net), Rebecca Nicholls(HealthInsight), Finlay Macrae(The Royal Melbourne Hospital), C. J. Vaizey(St Mark's Hospital), Gregory Moore(Monash Medical Centre), Alissa Walsh(John Radcliffe Hospital), Miles Sparrow(Alfred Health), David J. Hetzel(Royal Adelaide Hospital), Adèle Weston(HealthInsight), Christopher M. Black(Merck & Co., Inc., Rahway, NJ, USA (United States)), Warwick Selby(Royal Prince Alfred Hospital)
Cited by 114
Related Papers
Host–microbe interactions have shaped the genetic architecture of inflammatory bowel disease
|Nature|2012|4.8k
Celecoxib for the Prevention of Sporadic Colorectal Adenomas
|New England Journal of Medicine|2006|1k
Healing and relapse of severe peptic esophagitis after treatment with omeprazole
|Gastroenterology|1988|786
Inherited determinants of Crohn's disease and ulcerative colitis phenotypes: a genetic association study
|The Lancet|2015|779
A genetic linkage map of the bovine genome
|Nature Genetics|1994|539